The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin
Publication date: Available online 25 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Baode Shen, Chengying Shen, Weifeng Zhu, Hailong Yuan (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 26, 2021 Category: Cancer & Oncology Source Type: research
Targeting RAS phosphorylation in cancer therapy: Mechanisms and modulators
Publication date: Available online 25 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yuran Qiu, Yuanhao Wang, Zongtao Chai, Duan Ni, Xinyi Li, Jun Pu, Jie Chen, Jian Zhang, Shaoyong Lu, Chuan Lv, Mingfei Ji (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 26, 2021 Category: Cancer & Oncology Source Type: research
Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography−mass spectrometry
Publication date: Available online 26 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yang Yu, Changliang Yao, De-an Guo (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 26, 2021 Category: Cancer & Oncology Source Type: research
Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles
Publication date: Available online 24 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Anan Yaghmur, Huiling Mu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 25, 2021 Category: Cancer & Oncology Source Type: research
Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase
Publication date: Available online 15 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Quanjie Li, Dongrong Yi, Xiaobo Lei, Jianyuan Zhao, Yongxin Zhang, Xiangling Cui, Xia Xiao, Tao Jiao, Xiaojing Dong, Xuesen Zhao, Hui Zeng, Chen Liang, Lili Ren, Fei Guo, Xiaoyu Li, Jianwei Wang, Shan Cen (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 17, 2021 Category: Cancer & Oncology Source Type: research
Microneedle-based devices for point-of-care infectious disease diagnostics
Publication date: Available online 16 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Rachael V. Dixon, Eldhose Skaria, Wing Man Lau, Philip Manning, Mark A. Birch-Machin, S. Moein Moghimi, Keng Wooi Ng (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 17, 2021 Category: Cancer & Oncology Source Type: research
Synchronous conjugation of i-motif DNA and therapeutic siRNA on the vertexes of tetrahedral DNA nanocages for efficient gene silence
Publication date: Available online 12 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Xiu Han, Xiang Xu, Ziheng Wu, Zhenghong Wu, Xiaole Qi (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 14, 2021 Category: Cancer & Oncology Source Type: research
Table of Contents
Publication date: February 2021Source: Acta Pharmaceutica Sinica B, Volume 11, Issue 2Author(s): (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 11, 2021 Category: Cancer & Oncology Source Type: research
Cover Story
Publication date: February 2021Source: Acta Pharmaceutica Sinica B, Volume 11, Issue 2Author(s): (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 11, 2021 Category: Cancer & Oncology Source Type: research
LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase
Publication date: Available online 10 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Jie Zou, Xiaoyun Zhu, Dejuan Xiang, Yanqiu Zhang, Jie Li, Zhigui Su, Lingyi Kong, Hao Zhang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 11, 2021 Category: Cancer & Oncology Source Type: research
The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment
Publication date: Available online 11 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Hong Zhang, Liwu Fu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 11, 2021 Category: Cancer & Oncology Source Type: research
Applying artificial intelligence for cancer immunotherapy
Publication date: Available online 11 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Zhijie Xu, Xiang Wang, Shuangshuang Zeng, Xinxin Ren, Zhicheng Gong, Yuanliang Yan (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 11, 2021 Category: Cancer & Oncology Source Type: research
Cholesterol-associated lysosomal disorder triggers cell death of hematological malignancy: Dynamic analysis on cytotoxic effects of LW-218
Publication date: Available online 11 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Po Hu, Hui Li, Wenzhuo Sun, Hongzheng Wang, Xiaoxuan Yu, Yingjie Qing, Zhanyu Wang, Mengyuan Zhu, Jingyan Xu, Qinglong Guo, Hui Hui (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 11, 2021 Category: Cancer & Oncology Source Type: research
Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
Publication date: Available online 10 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Wenxiao Jiang, Guiqing Cai, Peter Hu, Yue Wang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 11, 2021 Category: Cancer & Oncology Source Type: research
Mitochondrial protein IF1 is a potential regulator of glucogan-like peptide (GLP-1) secretion function of mouse intestine
Publication date: Available online 8 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Ying Wang, Jiaojiao Zhang, Xinyu Cao, Yaya Guan, Shuang Shen, Genshen Zhong, Xiwen Xiong, Yanhong Xu, Xiaoying Zhang, Hui Wang, Jianping Ye (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 9, 2021 Category: Cancer & Oncology Source Type: research
